What is the recommended insulin regimen for a patient with diabetes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 30, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Insulin Cheat Sheet

Type 1 Diabetes: Basal-Bolus Regimen Required

Initial Dosing

  • Start with 0.5 units/kg/day total daily dose (TDD), split 50% basal and 50% prandial insulin 1
  • For a 70 kg patient: 35 units total = 17.5 units basal + 17.5 units prandial (divided among 3 meals: ~6 units each meal) 1
  • Metabolically stable patients typically need 0.5 units/kg/day; range is 0.4-1.0 units/kg/day 1
  • Higher doses needed during puberty, pregnancy, and acute illness (may exceed 1.0 units/kg/day) 1

Basal Insulin Options

  • Glargine (Lantus): Give once daily at same time; may require twice-daily dosing if inadequate 24-hour coverage 1
  • Detemir (Levemir): Often requires twice-daily dosing; total daily dose ~38% higher than glargine for equivalent control 1, 2
  • Degludec (Tresiba): Once daily dosing 3

Prandial Insulin

  • Rapid-acting analogs (lispro, aspart, glulisine): Give 0-15 minutes before meals 1, 4
  • Regular insulin: Give 30-45 minutes before meals 3, 4
  • Calculate using insulin-to-carbohydrate ratio: 450 ÷ TDD (for rapid-acting) or 500 ÷ TDD (for regular) 1
  • Example: TDD 50 units → ICR = 450÷50 = 1:9 (1 unit per 9g carbs) 1

Correction Doses

  • Insulin sensitivity factor (ISF) = 1500 ÷ TDD 1
  • Example: TDD 50 units → ISF = 30 (1 unit lowers glucose by 30 mg/dL) 1
  • Target preprandial glucose: 90-150 mg/dL 1

Type 2 Diabetes: Start Basal, Add Prandial if Needed

Starting Basal Insulin (Insulin-Naive Patients)

  • Start with 10 units once daily OR 0.1-0.2 units/kg/day 1
  • For a 70 kg patient: 7-14 units once daily 1
  • Continue metformin unless contraindicated 1
  • Give at same time daily (bedtime or with evening meal) 1, 2

Titration Algorithm

  • Target fasting glucose: 80-130 mg/dL 1
  • If FG 140-179 mg/dL: increase by 2 units every 3 days 1
  • If FG ≥180 mg/dL: increase by 4 units every 3 days 1
  • If hypoglycemia occurs: reduce dose by 10-20% 1

Severe Hyperglycemia (A1C ≥9%, glucose ≥300 mg/dL)

  • Start with 0.3-0.5 units/kg/day as basal-bolus regimen immediately 1
  • For a 70 kg patient: 21-35 units total = ~50% basal + ~50% prandial 1

Critical Threshold: When to Add Prandial Insulin

  • When basal insulin exceeds 0.5 units/kg/day without achieving A1C goal 1
  • When fasting glucose is controlled but A1C remains elevated after 3-6 months 1
  • Signs of overbasalization: bedtime-to-morning glucose drop ≥50 mg/dL, hypoglycemia, high glucose variability 1

Adding Prandial Insulin

  • Start with 4 units rapid-acting insulin before largest meal OR 10% of basal dose 1
  • Titrate by 1-2 units every 3 days based on 2-hour postprandial glucose 1
  • Target postprandial glucose: <180 mg/dL 1

Simplified Correction Insulin (Sliding Scale)

Use ONLY as adjunct to scheduled basal-bolus therapy, NEVER as monotherapy 1

  • Premeal glucose >250 mg/dL: add 2 units rapid-acting 1
  • Premeal glucose >350 mg/dL: add 4 units rapid-acting 1
  • Never give rapid-acting insulin at bedtime (nocturnal hypoglycemia risk) 1

Special Populations

Hospitalized Patients

  • Insulin-naive or low-dose: Start 0.3-0.5 units/kg/day (50% basal, 50% bolus) 1
  • High-dose home insulin (≥0.6 units/kg/day): Reduce by 20% on admission 1
  • Elderly, renal failure, poor oral intake: Start 0.1-0.25 units/kg/day 1
  • Target glucose: 140-180 mg/dL 1

Chronic Kidney Disease

  • CKD Stage 5 with Type 2 DM: Reduce TDD by 50% 1
  • CKD Stage 5 with Type 1 DM: Reduce TDD by 35-40% 1
  • Monitor closely for hypoglycemia 1

Steroid-Induced Hyperglycemia

  • Add 0.1-0.3 units/kg/day glargine to usual regimen 1
  • Increase prandial/correction insulin by 40-60% 1
  • Consider NPH in morning for daytime steroid effect 1

Insulin Pump Therapy (Type 1 DM)

  • Basal rate = 40-60% of TDD 1
  • Bolus = 40-60% of TDD (divided among meals and corrections) 1
  • ICR = 450 ÷ TDD 1
  • ISF = 1500 ÷ TDD 1

Premixed Insulin (70/30,75/25,50/50)

Type 2 Diabetes

  • Start 10 units twice daily (before breakfast and dinner) OR 0.1-0.2 units/kg/day divided 1
  • Titrate by 2-4 units every 3 days based on fasting and pre-dinner glucose 1
  • Transition to basal-bolus when dose exceeds 0.5 units/kg/day without achieving A1C goal 1

Avoid in hospitalized patients (high hypoglycemia risk) 1


Key Conversion Formulas

  • Glargine to Detemir: Detemir dose = Glargine dose × 1.38 1
  • IV to Subcutaneous: Subcutaneous TDD = ½ of 24-hour IV insulin 1
    • Give 50% as basal (evening), 50% as prandial (divided by 3) 1

Critical Pitfalls to Avoid

  • Never use sliding scale insulin as monotherapy 1
  • Never discontinue metformin when starting insulin (unless contraindicated) 1
  • Never continue escalating basal insulin beyond 0.5-1.0 units/kg/day without adding prandial coverage 1
  • Never delay insulin initiation in patients not achieving glycemic goals 1
  • Never give rapid-acting insulin at bedtime 1
  • Never mix or dilute glargine with other insulins 1

Hypoglycemia Management

  • Treat glucose <70 mg/dL with 15g fast-acting carbohydrate 1
  • Recheck in 15 minutes, repeat if needed 1
  • If hypoglycemia occurs: reduce corresponding insulin dose by 10-20% 1

Monitoring Requirements

  • Daily fasting glucose during titration 1
  • Pre-meal and 2-hour postprandial glucose when adjusting prandial insulin 1
  • A1C every 3 months during intensive titration 1
  • Reassess every 3-6 months once stable 1

References

Guideline

Initial Dosing for Lantus (Insulin Glargine) in Patients Requiring Insulin Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.